TI - Comparison of FOLFIRI and Paclitaxel as Second-Line Chemotherapy in Metastatic HER2-Negative Gastric Cancer: A Real-World Retrospective Analysis
PT - Journal Article
DP - 2026
TA - EJMI
PG - 345-358
VI - 10
IP - 3
AID - 269345 [doi]
4100 - https://dx.doi.org/10.14744/ejmi.269345
SO - EURASIAN JOURNAL OF MEDICIAL INVESTIGATION,2026 10(3): 345